By The Shin Kaneko laboratory at CiRA has developed a method to generate CAR-T cells from iPS cells (iCAR-T cells) that possess vastly improved anti-tumor activity in a mouse model of solid tumors.
Genetic modifications improve the therapeutic efficacy of iPSC-derived CAR-T cells against solid tumors
Focused chemists in lab coats and safety goggles making experiments.
Comments